
Clinical Trials - The Movement Towards Decentralized Clinical Trials
Description
Clinical Trials - The Movement Towards Decentralized Clinical Trials
Summary
This report provides an analysis on DCT's/Virtual trials.
Key Highlights
Summary
This report provides an analysis on DCT's/Virtual trials.
Key Highlights
- DCT usage is on the rise
- North America has conducted the most DCTs
- Mobile Healthcare is the top virtual component used
- The clinical trial data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The report focuses on DCT trials that were initiated between 2001 to 2022.
- The data have been analyzed by year, phase, status, therapy area, indication, geography, sponsor type (top industry sponsors versus non-industry sponsors), and reasons for discontinuation. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
- Provides a breakdown of DCT's across a number of clinical trial sectors.
- Identifies which areas are using DCT's the most.
- Highlights the use of DCT's in the industry and against institutional sponsors.
Table of Contents
31 Pages
- Executive Summary
- Introduction
- Report Scope
- Methodology
- Clinical Trials Landscape of Real-World Evidence Trials
- 2022 Projected to Be a Leading Year for DCTs
- The Largest Proportion of DCTs Are in Phase II
- Mobile Healthcare Is a Key Virtual Trial Component for DCTs
- North America Leads for DCTs
- North America Dominates for All Virtual Components
- North America leads Single-Country DCTs, Followed by Europe and Asia-Pacific
- US Leads DCT Usage
- Central Nervous System Is the Most Researched Therapy Area for DCTs
- Type 2 Diabetes Is the Most Researched Indication for DCTs
- Low Accrual Rate Is the Leading Cause of Trial Termination
- More Industry Trials Achieve Their Endpoints
- GSK Is the Top Industry Sponsor for DCTs
- Duke University Is the Top Non-Industry Sponsor for DCTs
- Key Findings
- Appendix
- List of Figures
- Figure 1: Number of DCTs by sponsor type and year
- Figure 2: DCTs by phase and status
- Figure 3: Virtual trial components by status
- Figure 4: DCTs by regional distribution
- Figure 5: Virtual components by region
- Figure 6: Single-country and multinational DCTs by region
- Figure 7: Distribution of DCTs by top five countries
- Figure 8: DCTs by therapy area
- Figure 9: DCTs by indication
- Figure 10: Reasons for trial discontinuation of DCTs
- Figure 11: Completed trials endpoint status, by sponsor type
- Figure 12: Top industry sponsors for DCTs
- Figure 13: Top non-industry sponsors for DCTs
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.